Scott Berry

7.8k total citations · 2 hit papers
72 papers, 3.2k citations indexed

About

Scott Berry is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Scott Berry has authored 72 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Oncology, 23 papers in Pulmonary and Respiratory Medicine and 18 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Scott Berry's work include Colorectal Cancer Treatments and Studies (36 papers), Cancer Treatment and Pharmacology (20 papers) and Economic and Financial Impacts of Cancer (13 papers). Scott Berry is often cited by papers focused on Colorectal Cancer Treatments and Studies (36 papers), Cancer Treatment and Pharmacology (20 papers) and Economic and Financial Impacts of Cancer (13 papers). Scott Berry collaborates with scholars based in Canada, United States and Spain. Scott Berry's co-authors include Malcolm J. Moore, Derek J. Jonker, Niall C. Tebbutt, Guy van Hazel, John Zalcberg, Marianne Krahn, Dongsheng Tu, Timothy Price, Christos S. Karapetis and Chris J. O’Callaghan and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Scott Berry

71 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cetuximab for the Treatment of Colorectal Cancer

2007 1.4k citations Derek J. Jonker, Chris J. O’Callaghan et al. New England Journal of Medicine profile →
American Society of Clinical Oncology Statement: Toward Individualized Care for Patients With Advanced Cancer

2011 388 citations Scott Berry et al. profile →

Peers

Scott Berry

ONCOL

PRM

HEPAT

PFM

Gianpiero Fasola Italy

Blasé N. Polite United States

Gary Richardson Australia

Claus‐Henning Köhne Germany

Russell B. McBride United States

Luigi Manzione Italy

Michael Findlay New Zealand

Heather‐Jane Au Canada

Joleen M. Hubbard United States

Jonathan M. Loree Canada

Gianpiero Fasola Italy

Scott Berry

2.0k ×0.9

ONCOL

1.3k ×1.1

PRM

257 ×0.5

HEPAT

598 ×1.4

377 ×0.9

PFM

Citations per year, relative to Scott Berry Scott Berry (= 1×) peers Gianpiero Fasola

Countries citing papers authored by Scott Berry

Since Specialization

Citations

This map shows the geographic impact of Scott Berry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Berry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Berry more than expected).

Fields of papers citing papers by Scott Berry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Berry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Berry. The network helps show where Scott Berry may publish in the future.

Co-authorship network of co-authors of Scott Berry

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Berry. A scholar is included among the top collaborators of Scott Berry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Berry. Scott Berry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gill, Sharlene, Shahid Ahmed, Scott Berry, et al.. (2023). Report from the 24th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Colorectal Cancer, Richmond, British Columbia, 28–29, October 2022. Current Oncology. 30(9). 7964–7983. 1 indexed citations

Gunasekera, Sanjeeva, Christopher M. Booth, Matthew Jalink, et al.. (2023). Breast Cancer-Related Financial Toxicity in Sri Lanka: Insights From a Lower Middle-Income Country With Free Universal Public Healthcare. The Oncologist. 29(2). e259–e265. 6 indexed citations

Raphael, Michael J., Mary A. De Vera, Darren R. Brenner, et al.. (2023). Breaking Down Barriers to Detection and Care in Early-Age-Onset Colorectal Cancer in Canada. Current Oncology. 30(11). 9392–9405. 3 indexed citations

Hammad, Nazik, Ntokozo Ndlovu, Doreen Ramogola‐Masire, et al.. (2023). Competency-Based Workforce Development and Education in Global Oncology. Current Oncology. 30(2). 1760–1775. 1 indexed citations

Chénard-Poirier, Maxime, Ravi Ramjeesingh, Vimoj Nair, et al.. (2023). Eastern Canadian Gastrointestinal Cancer Consensus Conference 2023. Current Oncology. 30(9). 8172–8185.

Wilson, Brooke E., et al.. (2023). First-line Palliative Chemotherapy for Colorectal Cancer: a Population-based Analysis of Delivery and Outcomes in a Single-payer Health System. Clinical Oncology. 36(4). 211–220. 1 indexed citations

Wijeratne, Don Thiwanka, Christopher M. Booth, Scott Berry, et al.. (2022). Colorectal Cancer Treatment Characteristics and Concordance With Guidelines in Sri Lanka: Results From a Hospital-Based Cancer Registry. JCO Global Oncology. 8(8). e2200004–e2200004. 2 indexed citations

Jalink, Matthew, Fábio Ynoe de Moraes, Christopher M. Booth, et al.. (2021). Tracking the Workforce 2020-2030: Making the Case for a Cancer Workforce Registry. JCO Global Oncology. 7(7). 925–933. 10 indexed citations

Rubagumya, Fidel, Wilma M. Hopman, Verna Vanderpuye, et al.. (2020). Training of oncologists: results of a global survey. ecancermedicalscience. 14. 1074–1074. 7 indexed citations

10.

Ezeife, Doreen A., François Dionne, Aline Fusco Fares, et al.. (2019). Value assessment of oncology drugs using a weighted criterion‐based approach. Cancer. 126(7). 1530–1540. 10 indexed citations

11.

Carrillo, Nuria, Marjan Huizing, Petcharat Leoyklang, et al.. (2019). Open-Label Phase 2 Clinical Trial of ManNAc for GNE Myopathy (S23.008). Neurology. 92(15_supplement). 1 indexed citations

12.

Abrahão, Ana Beatriz Kinupe, Safiya Karim, Brian Colwell, Scott Berry, & James Biagi. (2017). The Predictive Effect of Primary Tumour Location in the Treatment of Metastatic Colorectal Cancer: A Canadian Consensus Statement. Current Oncology. 24(6). 390–400. 7 indexed citations

13.

Abrahão, Ana Beatriz Kinupe, Yoo‐Joung Ko, Scott Berry, & Kelvin Chan. (2017). A Comparison of Regorafenib and TAS-102 for Metastatic Colorectal Cancer: A Systematic Review and Network Meta-analysis. Clinical Colorectal Cancer. 17(2). 113–120. 61 indexed citations

14.

Saad, Fred, Eric Winquist, Scott Berry, et al.. (2016). Efficacy, quality of life, and safety of cabazitaxel in Canadian metastatic castration-resistant prostate cancer patients treated or not with prior abiraterone. Canadian Urological Association Journal. 10(3-4). 102–102. 9 indexed citations

15.

Tam, Vincent C., Paris‐Ann Ingledew, Scott Berry, Sunil Verma, & Meredith Giuliani. (2016). Developing Canadian oncology education goals and objectives for medical students: a national modified Delphi study. CMAJ Open. 4(3). E359–E364. 6 indexed citations

16.

Gill, Sharlene, Scot Dowden, Bruce Colwell, Loretta L. Collins, & Scott Berry. (2014). Navigating later lines of treatment for advanced colorectal cancer – Optimizing targeted biological therapies to improve outcomes. Cancer Treatment Reviews. 40(10). 1171–1181. 13 indexed citations

17.

Lien, Kelly, Scott Berry, Yoo‐Joung Ko, & Kelvin Chan. (2014). The use of EGFR inhibitors in colorectal cancer: is it clinically efficacious and cost-effective?. Expert Review of Pharmacoeconomics & Outcomes Research. 15(1). 81–100. 5 indexed citations

18.

Cutsem, Eric Van, Fernando Rivera, Scott Berry, et al.. (2009). Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study. Annals of Oncology. 20(11). 1842–1847. 423 indexed citations

19.

Wierzbicki, Rafal, Derek J. Jonker, Malcolm J. Moore, et al.. (2009). A phase II, multicenter study of cetuximab monotherapy in patients with refractory, metastatic colorectal carcinoma with absent epidermal growth factor receptor immunostaining. Investigational New Drugs. 29(1). 167–174. 26 indexed citations

20.

Jonker, Derek J., Chris J. O’Callaghan, Christos S. Karapetis, et al.. (2007). Cetuximab for the Treatment of Colorectal Cancer. New England Journal of Medicine. 357(20). 2040–2048. 1413 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact